Cargando…
Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
Cholangiocarcinoma (CCA) is a disease with a very poor prognosis and limited treatment options. Although targeted therapies directed towards specific mutations found in CCA are becoming available and are showing great potential, many tumors do not carry actionable mutations and, in those that do, th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400764/ https://www.ncbi.nlm.nih.gov/pubmed/36045705 http://dx.doi.org/10.37349/etat.2021.00055 |